KC

Kiran Choudhary

Active Director Director DIN 10116322
DIN 10116322 First appointment Apr 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiran Choudhary

Data last updated:

Kiran Choudhary is a Director at Vs Arogya Meda Private Limited (since 2024) and Director at Medicaplus Lifesaving Private Limited (since 2023).

DIN 10116322
Primary Designation Director
First Appointment 17 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vs Arogya Meda Private Limited U47721JH2024PTC021827
Director09 Jan 20242024Active
Director17 Apr 20232023Active

Board colleagues of Kiran Choudhary

Directorship timeline

Open interactive timeline →
Medicaplus Lifesaving Private Limited
Vs Arogya Meda Private Limited
Premium access

Shareholding and investment profile for Kiran Choudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Choudhary

Kiran Choudhary currently holds 2 directorships: Vs Arogya Meda Private Limited (Director, since 09 Jan 2024); Medicaplus Lifesaving Private Limited (Director, since 17 Apr 2023).

Kiran Choudhary was first appointed on 17 Apr 2023 as Director at Medicaplus Lifesaving Private Limited. The most recent appointment on record is 09 Jan 2024 at Vs Arogya Meda Private Limited.

The current boards of Kiran Choudhary's companies include Manoj Kumar Choudhary (Vs Arogya Meda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available